45.83
-1.22 (-2.59%)
| Previous Close | 47.05 |
| Open | 46.58 |
| Volume | 185,023 |
| Avg. Volume (3M) | 333,901 |
| Market Cap | 1,665,879,296 |
| Price / Earnings (Forward) | 9.97 |
| Price / Sales | 1.16 |
| Price / Book | 7.98 |
| 52 Weeks Range | |
| Earnings Date | 19 Feb 2025 - 24 Feb 2025 |
| Profit Margin | -38.11% |
| Operating Margin (TTM) | 22.42% |
| Diluted EPS (TTM) | -15.51 |
| Quarterly Revenue Growth (YOY) | -15.50% |
| Total Debt/Equity (MRQ) | 726.34% |
| Current Ratio (MRQ) | 1.76 |
| Operating Cash Flow (TTM) | 110.30 M |
| Levered Free Cash Flow (TTM) | 236.71 M |
| Return on Assets (TTM) | 5.85% |
| Return on Equity (TTM) | -120.81% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Chemicals (US) | Bullish | Bullish |
| Specialty Chemicals (Global) | Bullish | Bullish | |
| Stock | Ingevity Corporation | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.75 |
|
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America. |
|
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Investment Style | Small Value |
| % Held by Insiders | 0.88% |
| % Held by Institutions | 101.63% |
| 52 Weeks Range | ||
| Median | 47.00 (2.55%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BMO Capital | 31 Oct 2024 | 47.00 (2.55%) | Hold | 41.79 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 16 Dec 2024 | Announcement | Ingevity elects Kevin Willis to its board of directors |
| 29 Oct 2024 | Announcement | Ingevity reports third quarter 2024 financial results |
| 16 Oct 2024 | Announcement | Ingevity updates third-quarter 2024 earnings release and webcast dates |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |